|
Forecast
Period
|
2026-2030
|
|
Market
Size (2024)
|
USD
1599.70 Million
|
|
Market
Size (2030)
|
USD 2427.89 Million
|
|
CAGR
(2025-2030)
|
7.16%
|
|
Fastest
Growing Segment
|
Surgical
Devices
|
|
Largest
Market
|
North
India
|
Market Overview
India Cardiovascular Devices Market was valued at USD 1599.70 million in 2024 and is anticipated to reach USD 2427.89 Million by 2030, with a CAGR of 7.16% during 2025-2030. Cardiovascular devices constitute a broad category of medical equipment tailored to diagnose, monitor, treat, or manage conditions pertaining to the cardiovascular system, encompassing the heart and blood vessels. These devices play a pivotal role in the realm of cardiology, offering versatile applications ranging from diagnosing heart conditions to delivering life-saving interventions. In India, the aging demographic faces heightened susceptibility to cardiovascular diseases, necessitating a greater demand for cardiovascular devices and associated services. Continued technological advancements in the cardiovascular device sector have yielded more efficacious and sophisticated devices, propelling market expansion as healthcare providers strive to deliver cutting-edge care.
The escalating prevalence of cardiovascular diseases in India, such as heart disease and hypertension, serves as a key growth driver, fueling demand for cardiovascular devices for diagnostic and therapeutic purposes. Government-sponsored healthcare programs and initiatives targeting the mounting burden of cardiovascular ailments have the potential to further stimulate demand for cardiovascular devices by allocating funds for medical equipment and infrastructure enhancements. The proliferation of healthcare infrastructure, encompassing hospitals and specialized cardiac care centers, also contributes to market growth, as these facilities necessitate a diverse array of cardiovascular devices for comprehensive diagnosis and treatment protocols.
A burgeoning awareness of cardiovascular health in India, fostered by awareness campaigns, educational endeavors, and preventive measures, underscores the rising demand for diagnostic and monitoring devices tailored to cardiovascular health management. Regulatory dynamics and evolving standards governing medical devices in India exert a substantial influence on the approval and commercialization of cardiovascular devices. Manufacturers must adhere to these regulations to gain entry and thrive in the market landscape.
Key Report Takeaway
- Diagnostic and monitoring devices led the type segment in 2024, supported by widespread use of blood pressure monitors, ECG machines, and Holter monitors in clinics and homes
- Growing awareness of heart health, expansion of telemedicine, and rising home health care services increased the use of cardiac monitoring devices
- Coronary artery disease dominated the application segment, as high disease prevalence in India drives demand for imaging tools, angioplasty procedures, and coronary stents
- North India led regionally, supported by strong hospital infrastructure, higher income levels, a large patient base, and growth in medical tourism in cities such as Delhi
Key Market Drivers
Technological Advancements
Technological advancements are transforming India’s cardiovascular devices landscape by making diagnosis, intervention, and follow-up care more precise, less invasive, and more widely available across leading hospitals. Drug-eluting stents and advanced catheterization technologies are strengthening coronary care, with Abbott launching the XIENCE Sierra coronary stent in India and stating that it is also supporting cardiologists with AI-enabled imaging tools and diagnostics for complex interventions. For instance, Philips announced that it has crossed 1,500 cath lab installations in India and South Asia, highlighting the rapid expansion of image-guided therapy, IVUS, iFR, and hemodynamic monitoring capabilities that help clinicians assess coronary blockages with greater precision.
Robotic and minimally invasive cardiac procedures are also gaining momentum, as Apollo Hospitals Chennai reported completing 500 robotic cardiac procedures, showing how major private hospital groups are investing in technologies that can reduce surgical trauma and improve recovery. Alongside implantable devices, remote monitoring, AI-led analytics, and digitally connected cardiac platforms are helping care teams detect complications earlier, personalize treatment decisions, and improve efficiency, making technology one of the strongest growth drivers for cardiovascular devices in India.
Rising Aging Population
India’s rapidly expanding elderly population is becoming a major force behind cardiovascular device demand, as the country had 149 million people aged 60 and above in 2022 and is projected to reach 347 million by 2050, while recent evidence shows cardiovascular diseases account for nearly one-third of deaths in India and 29.4% of adults aged 45 years and above report a confirmed cardiovascular condition. The burden becomes sharper with age, with research showing heart attack prevalence rising from 2.1% among people aged 45 to 49 to 8.2% among those aged 80 to 84, while heart failure reaches 3.5% in the 80 to 84 age group, reinforcing the need for sustained cardiac monitoring, imaging, and device-based treatment in older patients.
For instance, Philips announced in 2024 that it had crossed 1,500 cath lab installations in the Indian subcontinent, with systems deployed across major cities such as Delhi, Bengaluru, Mumbai, Kolkata, Hyderabad, Chennai, and Pune, reflecting how leading companies are expanding interventional cardiology capacity to meet rising age-linked cardiac demand.
Innovation is also making care more suitable for seniors, as Medtronic stated that its Micra AV2 and Micra VR2 leadless pacemakers deliver nearly 16 and 17 years of projected battery life, may enable more than 80% of patients to require only one device for life, and include remote monitoring capabilities that can reduce unnecessary hospital visits for older adults.
Major private providers are already translating these technologies into practice, with Apollo Hospitals reporting 500 robotic cardiac procedures in Chennai, highlighting growing use of minimally invasive cardiac interventions that can support faster recovery in elderly patients. As longevity rises and multimorbidity becomes more common in India, the stronger presence of cath labs, smart implantable devices, and advanced minimally invasive cardiac technologies is steadily increasing the need for cardiovascular devices across the country.
Increasing Awareness and Prevention Efforts
Awareness campaigns and preventive measures play a pivotal role in educating the population about the risk factors and warning signs of cardiovascular diseases. This heightened awareness encourages individuals to seek early diagnosis, often facilitated by the use of cardiovascular devices such as blood pressure monitors and ECG machines. Health education initiatives promote healthier lifestyles, including dietary improvements and regular physical activity, which can mitigate the risk of cardiovascular diseases, emphasizing prevention as a crucial aspect of healthcare.
Individuals who are aware of their cardiovascular risk factors, such as hypertension or elevated cholesterol levels, are more inclined to utilize monitoring devices at home, including wearable fitness trackers and blood pressure monitors, for self-assessment. Screening and check-up programs, integral to awareness initiatives, offer access to diagnostic tests and assessments using cardiovascular devices, aiding in early detection of risk factors and conditions. Cardiovascular risk assessments, conducted with diagnostic devices, empower individuals to understand their specific risk profile, enabling healthcare providers to deliver personalized recommendations and interventions. The rising awareness of telemedicine and telehealth services facilitates convenient consultations for cardiovascular risk assessment and prevention, leveraging remote monitoring devices and telehealth platforms.
Government and public health organizations drive initiatives to promote cardiovascular health, including the distribution of diagnostic devices like blood pressure monitors to underserved communities. Healthcare professionals are also targeted for education on the latest advancements in cardiovascular devices and treatment options, subsequently informing patients. Community and workplace awareness programs integrate preventive interventions and wellness initiatives, often incorporating fitness trackers and other devices for monitoring physical activity and heart health. Highlighting the cost-effectiveness of prevention over treatment, awareness campaigns focus on reducing the economic burden of cardiovascular diseases, thus fostering demand for devices supporting prevention. This trend contributes to the accelerated growth of the India Cardiovascular Devices Market.
Download Free Sample Report
Key Market Challenges
Cost and Affordability
The costliness of many cardiovascular devices, including implantable pacemakers, stents, and advanced diagnostic equipment, presents a significant hurdle for both patients and healthcare facilities, impacting the adoption of these devices. India's population exhibits diverse income levels, with a considerable segment falling within the low to middle-income brackets. For individuals in these economic strata, the expense associated with cardiovascular devices often proves prohibitive.
Health insurance coverage remains incomplete, leaving many patients to cover medical expenses out of pocket. Consequently, the high out-of-pocket costs linked with cardiovascular procedures and devices dissuade individuals from seeking timely medical attention. In rural areas, where access to specialized cardiac care is limited, patients encounter additional financial burdens associated with travel and accommodation when seeking treatment in urban centers. Complex cardiac procedures, such as coronary artery bypass surgery or the insertion of advanced cardiac devices, entail substantial costs, further deterring patients from pursuing these treatments. India's reliance on imported medical devices amplifies the financial burden due to import duties and currency exchange rates.
Many individuals lack adequate health insurance coverage for cardiovascular procedures or devices, leaving them to shoulder the entirety of the financial burden. While government healthcare initiatives exist, funding may fall short of addressing the population's cardiovascular device needs, exacerbating affordability challenges. Moreover, the long-term need for cardiovascular medications adds to the financial strain for patients, potentially impeding medication adherence. These affordability constraints underscore the complexities associated with accessing cardiovascular care in India, posing challenges for patients and healthcare providers alike.
Import Dependence
Reliance on imports exposes the market to foreign currency exchange rate fluctuations. Variations in exchange rates can significantly affect the cost of imported devices, potentially making them more expensive for Indian consumers and health care providers.
Imported medical devices also carry added costs, including import tariffs and customs duties. These expenses can raise the overall cost of cardiovascular devices and make them less affordable for end users.
Dependence on imports also leaves the supply chain more vulnerable to disruption, including global economic downturns, geopolitical tensions and trade disputes. These disruptions can delay the availability of cardiovascular devices in the Indian market.
Higher device costs can create barriers for both health care facilities and patients. As prices rise, access to imported devices may become more limited for a broader population.
Ensuring the quality and safety of imported cardiovascular devices can also be challenging because regulations and standards vary by country. Strong regulatory compliance and quality control measures remain essential to protect patient safety.
Dependence on foreign manufacturers also limits the Indian market's control over the production and supply of cardiovascular devices. This can create uncertainty around both device availability and pricing.
Key Market Trends
Shift Towards Minimally Invasive Procedures
Patients often prefer minimally invasive procedures to traditional open-heart surgery because they usually involve smaller incisions, less pain, shorter hospital stays and faster recovery times.
Because these procedures are less disruptive to the body, they can lead to fewer complications, reduced scarring and a quicker return to daily activities. Technological advances have also made minimally invasive techniques more feasible and effective. Devices such as catheters, endoscopic tools and imaging systems have improved precision and safety.
Minimally invasive procedures can also be more cost-effective for patients and health care providers because they shorten hospital stays and reduce post-operative care requirements. They often carry lower risks of infection, bleeding and other complications, making them an attractive option for patients with multiple comorbidities. Reduced physical trauma can be especially beneficial for older adults and patients with frail health.
Patients who undergo minimally invasive procedures typically recover more quickly and can return to daily routines sooner. This is especially important for those who need to resume work or caregiving responsibilities. These techniques have also improved diagnostic and interventional procedures, including percutaneous coronary intervention, or PCI, such as angioplasty and stent placement, which are essential in managing coronary artery disease.
Minimally invasive procedures can often reach areas that are difficult to access through traditional surgery, making them particularly valuable in complex cases.
Segmental Insights
Type Insights
In 2024, the largest share of the India cardiovascular devices market was held by the diagnostic and monitoring devices segment and is expected to continue expanding in the coming years. Diagnostic and monitoring devices, such as blood pressure monitors, electrocardiogram machines and Holter monitors, are widely used in clinical settings and at home. Their broad adoption has helped this segment maintain its leading position.
Greater awareness of heart health and cardiovascular risk factors has led more people to monitor their heart health regularly. This includes routine blood pressure checks and electrocardiogram recordings, especially among people with risk factors such as hypertension and diabetes. The COVID-19 pandemic also accelerated telemedicine and remote monitoring in India, increasing the use of digital devices for cardiac monitoring.
The rise of home health care services has further increased demand for easy-to-use devices such as blood pressure monitors. India's aging population also faces a higher risk of cardiovascular disease, prompting many older adults and caregivers to use monitoring devices to manage and track heart health. Health care professionals rely on these devices for preliminary assessments, follow-up care and risk evaluation, making them essential to informed patient care decisions.
Application Insights
In 2024, the largest share of the India cardiovascular devices market was held by the coronary artery disease segment and is expected to continue expanding in the coming years. Coronary artery disease is one of the most prevalent cardiovascular conditions in India, particularly in urban and semi-urban areas. This high disease burden is driving demand for devices designed for the diagnosis and treatment of coronary artery disease.
The condition often requires advanced diagnostic tools, such as angiography machines, computed tomography angiography and intravascular ultrasound devices. These technologies help physicians diagnose the extent of coronary blockages, guide treatment decisions and assess outcomes. Coronary artery disease also frequently requires interventional procedures such as angioplasty and stent placement.
Demand remains strong for coronary stents, including drug-eluting stents, bare-metal stents and bioresorbable stents, because of the need for percutaneous coronary intervention in these patients. The segment also benefits from continued advances in imaging, catheter-based intervention and device materials, which are improving the safety and effectiveness of treatment. Lifestyle-related risk factors, including poor diet, physical inactivity, smoking and hypertension, continue to contribute to the high prevalence of coronary artery disease in India and often increase the need for medical intervention involving cardiovascular devices.
Download Free Sample Report
Regional Insights
North India dominated the India cardiovascular devices market in 2024. The region, particularly Delhi, has well-established health care infrastructure, including many leading hospitals and cardiac care centers. This concentration of high-quality medical facilities, equipped with advanced cardiovascular devices and technology, supports strong market demand.
North India is also one of the country's more economically prosperous regions. As a result, people in the region often have better access to health care services, including cardiovascular care. Higher average income levels can also increase demand for advanced cardiovascular devices and procedures.
The region is home to a significant share of India's population, including densely populated urban centers. This larger population base often corresponds with a higher prevalence of cardiovascular disease, driving demand for cardiovascular devices and treatment.
North India also hosts many prestigious educational and research institutions that often collaborate with health care facilities on research and development. These partnerships support innovation and encourage adoption of advanced cardiovascular technologies across the region.
Delhi and nearby areas are also popular destinations for medical tourism. International patients seeking cardiovascular care often choose the region for its advanced facilities and clinical expertise. This trend further increases demand for cardiovascular devices and related services.
Recent Developments
- In December 2025, Meril’s LANDMARK trial update was highlighted as a milestone for Indian cardiovascular MedTech because the Myval THV series was evaluated head-to-head against leading international transcatheter valve platforms across a multicenter global study.
- In November 2025, Meril Life Sciences presented one-year outcomes from the LANDMARK randomized controlled trial for its Myval THV series at PCR London Valves 2025, marking a major company update for an Indian-developed transcatheter heart valve platform.
- In October 2025, Medtronic launched its Avalus Ultra surgical aortic bioprosthesis in India, expanding its cardiac surgery portfolio with a next-generation valve designed to simplify implantation and support long-term patient management.
Key
Market Players
|
|
|
|
|
- Diagnostic & Monitoring Devices
- Surgical Devices
|
·
Coronary Artery Disease
·
Cardiac Arrhythmia
·
Heart Failure
·
Others
|
·
Hospitals & Clinics
·
Diagnostic Centers
·
Others
|
· North India
·
South India
·
East India
·
West India
|
Report Scope:
In this report, the India Cardiovascular Devices Market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- India Cardiovascular
Devices Market, By
Type:
o Diagnostic & Monitoring Devices
o Surgical Devices
- India Cardiovascular
Devices Market, By
Application:
o Coronary Artery Disease
o Cardiac Arrhythmia
o Heart Failure
o Others
- India Cardiovascular
Devices Market, By End-User:
o Hospitals & Clinics
o Diagnostic Centers
o Others
- India Cardiovascular Devices Market, By Region:
o North India
o
South
India
o
East
India
o
West India
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the India
Cardiovascular Devices Market.
Available Customizations:
India Cardiovascular Devices Market report
with the given market data, Tech Sci Research offers customizations according
to a company's specific needs. The following customization options are
available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
India Cardiovascular Devices Market is an upcoming
report to be released soon. If you wish an early delivery of this report or
want to confirm the date of release, please contact us at [email protected]